Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes.
作者信息
Hudson Janella, Munoz-Antonia Teresita, Haura Eric, Cress Doug, Simmons Vani N, Quinn Gwendolyn P
机构信息
Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States.
出版信息
Gene Cell Tissue. 2016 Apr;3(2). doi: 10.17795/gct-35961. Epub 2016 Feb 14.
Abstract
摘要
相似文献
1
Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes.将西班牙裔肺癌基因组因素转化为临床实践：进行表皮生长因子受体检测以改善治疗结果
Gene Cell Tissue. 2016 Apr;3(2). doi: 10.17795/gct-35961. Epub 2016 Feb 14.
2
Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.2010 年至 2013 年间，医疗保险肺癌患者的表皮生长因子受体（EGFR）检测利用不足以及获得检测的机会存在差异。
BMC Cancer. 2018 Mar 20;18(1):306. doi: 10.1186/s12885-018-4190-3.
3
Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP).西班牙裔人群中表皮生长因子受体突变阳性肺腺癌患者对厄洛替尼获得性耐药（CLICaP）
Target Oncol. 2017 Aug;12(4):513-523. doi: 10.1007/s11523-017-0497-2.
4
Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.韩国晚期非小细胞肺癌患者表皮生长因子受体突变伴随诊断检测及一线靶向治疗的经济学评估
PLoS One. 2016 Aug 2;11(8):e0160155. doi: 10.1371/journal.pone.0160155. eCollection 2016.
5
Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.新诊断的转移性肺癌患者中表皮生长因子受体（EGFR）突变检测的应用模式与趋势
Clin Lung Cancer. 2017 Jul;18(4):e233-e241. doi: 10.1016/j.cllc.2016.11.002. Epub 2016 Nov 11.
6
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).肺腺癌中西班牙裔人群的 EGFR 外显子 20 插入（geno1.2-CLICaP）。
Lung Cancer. 2018 Nov;125:265-272. doi: 10.1016/j.lungcan.2018.10.007. Epub 2018 Oct 9.
7
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.肺腺癌患者的基因组分析揭示了治疗靶点，并在标准分子检测呈阴性时带来临床益处。
Oncotarget. 2016 Apr 26;7(17):24172-8. doi: 10.18632/oncotarget.8138.
8
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.应用基于扩增子的靶向测序与分子条形码系统检测未经治疗的肺腺癌患者中罕见的次要 EGFR 突变。
BMC Cancer. 2019 Feb 26;19(1):175. doi: 10.1186/s12885-019-5374-1.
9
Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care system.在公共资助的医疗保健系统中实施表皮生长因子受体检测策略治疗非小细胞肺癌所面临的挑战。
J Thorac Oncol. 2013 Sep;8(9):1136-41. doi: 10.1097/JTO.0b013e31829f6a43.
10
Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration.美国退伍军人健康管理局（Veterans Health Administration）中接受肺癌治疗的退伍军人围绕基因组和蛋白质组检测的临床决策。
BMC Med Inform Decis Mak. 2017 May 30;17(1):71. doi: 10.1186/s12911-017-0475-8.
本文引用的文献
1
Racial Differences in Awareness of the Affordable Care Act and Application Assistance Among Low-Income Adults in Three Southern States.美国南部三个州低收入成年人对《平价医疗法案》的认知及申请援助的种族差异
Inquiry. 2015 Oct 8;52. doi: 10.1177/0046958015609607. Print 2015.
2
Cancer statistics for Hispanics/Latinos, 2015.2015 年西班牙裔/拉丁裔癌症统计数据。
CA Cancer J Clin. 2015 Nov-Dec;65(6):457-80. doi: 10.3322/caac.21314. Epub 2015 Sep 16.
3
Impact of care at comprehensive cancer centers on outcome: Results from a population-based study.综合癌症中心的护理对治疗结果的影响：一项基于人群研究的结果
Cancer. 2015 Nov 1;121(21):3885-93. doi: 10.1002/cncr.29576. Epub 2015 Jul 28.
4
Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS Database Study.肺癌手术分期中的种族和民族差异：一项胸外科医师学会数据库研究
Thorac Cardiovasc Surg. 2015 Oct;63(7):538-43. doi: 10.1055/s-0035-1546295. Epub 2015 May 18.
5
Equity in Lung Cancer Care and Outcomes.肺癌治疗与结局的公平性。
J Gen Intern Med. 2015 Oct;30(10):1385-6. doi: 10.1007/s11606-015-3346-y.
6
Triple-negative breast cancer in African-American women: disparities versus biology.非裔美国女性的三阴性乳腺癌：差异与生物学特性
Nat Rev Cancer. 2015 Apr;15(4):248-54. doi: 10.1038/nrc3896. Epub 2015 Feb 12.
7
Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).拉丁美洲非小细胞肺癌中 EGFR 和 KRAS 基因突变的更新频率：拉丁美洲肺癌研究联合会（CLICaP）。
J Thorac Oncol. 2015 May;10(5):838-843. doi: 10.1097/JTO.0000000000000481.
8
Lung cancer mutations and use of targeted agents in Hispanics.西班牙裔人群中的肺癌突变与靶向药物的使用
Rev Recent Clin Trials. 2014;9(4):225-32. doi: 10.2174/1574887110666150127103555.
9
Racial differences in lung cancer genetics.肺癌遗传学中的种族差异。
J Thorac Oncol. 2015 Feb;10(2):230-1. doi: 10.1097/JTO.0000000000000439.
10
Recent advances in personalized lung cancer medicine.个性化肺癌医学的最新进展。
Per Med. 2014;11(3):309-321. doi: 10.2217/pme.14.19.
Zotero 插件